Jushi Holdings (JUSHF) Return on Capital Employed (2022 - 2026)
Jushi Holdings (JUSHF) reported Return on Capital Employed of 2.35% for Q1 2026, up 105.0% year-over-year from 1.15% in Q1 2025, and up 74.68% quarter-over-quarter from 1.34% in Q4 2025.
Jushi Holdings (JUSHF) Return on Capital Employed (2022 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 5 years of Return on Capital Employed data on file, last reported at 2.35% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 2.35%, up 105.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 2.35% (up 105.0% YoY), and the FY2025 annual result was 1.33%, down 151.0% from the prior year.
- Return on Capital Employed improved to 2.35% in Q1 2026 per JUSHF's latest filing, from 1.34% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 2.92% in Q4 2024 and troughed at 49.89% in Q1 2023.
- A 5-year average of 12.57% and a median of 0.35% in 2025 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed slumped 3827 bps in 2023, then soared 5157 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 44.91% in 2022, then soared by 98 bps to 0.9% in 2023, then surged by 425 bps to 2.92% in 2024, then slumped by 54 bps to 1.34% in 2025, then jumped by 75 bps to 2.35% in 2026.
- Business Quant data shows JUSHF's Return on Capital Employed at 2.35% in Q1 2026, 1.34% in Q4 2025, and 0.69% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Jushi Holdings | - | - | 29.88 Mn | 2.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.35% |
| Dec 31, 2025 | 1.34% |
| Sep 30, 2025 | 0.69% |
| Jun 30, 2025 | 0.02% |
| Mar 31, 2025 | 1.29% |
| Dec 31, 2024 | 2.92% |
| Sep 30, 2024 | 1.63% |
| Jun 30, 2024 | 2.30% |
| Mar 31, 2024 | 1.29% |
| Dec 31, 2023 | -0.90% |
| Sep 30, 2023 | -35.77% |
| Jun 30, 2023 | -49.27% |
| Mar 31, 2023 | -49.89% |
| Dec 31, 2022 | -44.91% |
| Sep 30, 2022 | -23.24% |
| Jun 30, 2022 | -11.00% |